Cargando…
lncRNAs as potential molecular biomarkers in the clinicopathology and prognosis of cholangiocarcinoma: a systematic review and meta-analysis
BACKGROUND: Cholangiocarcinoma (CCA) is the second most common fatal primary hepatobiliary malignant carcinoma, characterized by early invasion and extremely poor outcomes. It is therefore necessary to identify a novel biomarker to better diagnose CAA and predict its prognosis. Recently, emerging ev...
Autores principales: | Dai, Kangfu, Quan, Jing, Yan, Fangli, Jin, Xinghan, Pan, Xiang, Song, Xiaorui, Zhang, Shijie, Ren, Qingqi, Liu, Jikui, Liu, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415731/ https://www.ncbi.nlm.nih.gov/pubmed/30881042 http://dx.doi.org/10.2147/OTT.S188134 |
Ejemplares similares
-
LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL
por: Huang, Xuanmei, et al.
Publicado: (2021) -
Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2021) -
Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma
por: Dai, Meiyu, et al.
Publicado: (2017) -
Characterization and Prognosis of Biological Microenvironment in Lung Adenocarcinoma through a Disulfidptosis-Related lncRNAs Signature
por: Yang, Zhuo, et al.
Publicado: (2023) -
Identification of the Prognosis-Related lncRNAs and Genes in Gastric Cancer
por: Su, Xiaohui, et al.
Publicado: (2020)